These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7660007)
1. [Future vaccines]. Tron F Rev Prat; 1995 Jun; 45(12):1514-9. PubMed ID: 7660007 [TBL] [Abstract][Full Text] [Related]
2. Fish vaccine antigens produced or delivered by recombinant DNA technologies. Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855 [TBL] [Abstract][Full Text] [Related]
4. The future of respiratory syncytial virus vaccine development. Polack FP; Karron RA Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S65-73. PubMed ID: 14730272 [TBL] [Abstract][Full Text] [Related]
5. [Research and development strategies, examples among new vaccines]. Denis F; Ploy MC Ann Pharm Fr; 2009 May; 67(3):198-202. PubMed ID: 19446670 [TBL] [Abstract][Full Text] [Related]
6. Review article: vaccination and viral hepatitis - current status and future prospects. Koff RS Aliment Pharmacol Ther; 2007 Nov; 26(10):1285-92. PubMed ID: 17868433 [TBL] [Abstract][Full Text] [Related]
7. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice. Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041 [TBL] [Abstract][Full Text] [Related]
8. New concepts in vaccine development in malaria. Kanoi BN; Egwang TG Curr Opin Infect Dis; 2007 Jun; 20(3):311-6. PubMed ID: 17471043 [TBL] [Abstract][Full Text] [Related]
9. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
10. New vaccination strategies for low- and non-responders to hepatitis B vaccine. Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305 [TBL] [Abstract][Full Text] [Related]
11. Human vaccines. Ada GL Dev Biol Stand; 1994; 82():181-8. PubMed ID: 7958473 [TBL] [Abstract][Full Text] [Related]
12. Genetically engineered viral vaccines--prospects for the future. Pettersson RF Ann Clin Res; 1982 Dec; 14(5-6):245-52. PubMed ID: 6763495 [TBL] [Abstract][Full Text] [Related]
13. [Antiviral vaccines]. Girard M Med Trop (Mars); 1999; 59(4 Pt 2):522-6. PubMed ID: 10901858 [TBL] [Abstract][Full Text] [Related]
14. New Principles of Development of Preparations for Immunoprophylaxis. Vorobyev AA; Medunitsyn NV Russ J Immunol; 1999 Dec; 4(4):352-354. PubMed ID: 12687155 [TBL] [Abstract][Full Text] [Related]
15. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants]. Koprowski H Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429 [TBL] [Abstract][Full Text] [Related]
16. Application of new vaccine technologies for the control of transboundary diseases. Swayne DE Dev Biol (Basel); 2004; 119():219-28. PubMed ID: 15742632 [TBL] [Abstract][Full Text] [Related]
17. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines. Brandler S; Tangy F Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338 [TBL] [Abstract][Full Text] [Related]
18. New approaches in vaccine development. Leclerc C Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults. Raz R; Koren R; Bass D Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]